News - Dermatologic disorders
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 





DateSubject
02/03/2010 02:46:27 PM
Antimicrobial Treatment for Buruli Ulcer Is Effective In Early, Limited Disease
02/03/2010 10:18:28 AM
01/28/2010 12:29:12 PM
Immune Cell Levels Predict Skin Cancer Risk in Kidney Transplant Patients
01/20/2010 11:25:21 AM
Adalimumab Approved in Japan for Plaque Psoriasis, Psoriatic Arthritis
01/05/2010 12:30:07 PM
Health Canada Approves Imiquimod Cream for Actinic Keratosis
12/21/2009 03:36:45 PM
Heart Transplant Patients Appear to Have Elevated Risk for Multiple Skin Cancers
12/10/2009 05:53:42 PM
Skin Cancers Observed More Frequently in Patients With CLL Than in General Population: Presented at ASH
12/07/2009 04:11:53 PM
Melphalan Better Partner With Bortezomib for Older Patients With Untreated Multiple Myeloma: Presented at ASH
12/07/2009 03:01:11 PM
Neutropenia Not a Barrier to Long-Term Lenalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: Presented at ASH
12/06/2009 02:22:48 PM
Elastography Can Help Distinguish Between Cancerous and Benign Skin Growths: Presented at RSNA
11/10/2009 03:03:56 PM
Blood Flow Cytometry May Be Preferable Way to Diagnose, Analyse Mycosis Fungoides: Presented at ASCP
10/31/2009 10:48:56 AM
Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin Cancer in Kidney Transplant Patients: Presented at Renal Week 2009
10/22/2009 02:36:15 PM
Belimumab Reduces Systemic Lupus Erythematosus Disease Activity, Flares, and Prednisone Usage: Presented at ACR/ARHP
10/21/2009 04:24:01 PM
Lenalidomide Plus Low-Dose Dexamethasone Improves Short-Term Survival in Newly Diagnosed Myeloma
10/21/2009 02:51:54 PM
Spinosad Better Than Permethrin for Pediculosis Capitis in Children: Presented at AAP
10/15/2009 02:44:38 PM
Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV
10/14/2009 03:34:22 PM
Fumaric Acid Ester Safe and Effective Against Psoriasis in Patients Receiving Medication for Comorbidities: Presented at EADV
10/14/2009 12:23:11 PM
Infliximab More Effective Than Methotrexate in Patients With Moderate to Severe Plaque Psoriasis: Presented at EADV
10/13/2009 03:09:40 PM
Patients With Psoriasis Experience Improved Quality of Life Following Adalimumab Treatment: Presented at EADV
10/13/2009 02:59:49 PM
Adalimumab Yields Fast and Sustainable Scalp and Nail Results in Patients With Psoriasis: Presented at EADV
10/13/2009 02:24:30 PM
Mycophenolate Mofetil Benefits Patients With Pemphigus Vulgaris: Presented at EADV
10/13/2009 02:02:57 PM
Combination Gel Controls Propionibacterium acnes Without Irritation or Development of Microbial Resistance: Presented at EADV
10/13/2009 11:20:12 AM
Comorbidities of Psoriasis Create Higher Healthcare Costs: Presented at EADV
10/13/2009 11:06:56 AM
Benzoyl Peroxide Plus Clindamycin Gel Improves Quality of Life in Patients With Mild to Moderate Acne: Presented at EADV
10/12/2009 06:02:55 PM
New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV
10/12/2009 05:58:52 PM
Systemic Treatment With Biologics, Especially Infliximab, Is the Most Cost-Effective Therapy for Patients With Mild to Severe Psoriasis: Presented at EADV
10/12/2009 11:56:45 AM
Continuous Treatment With Etanercept Effective in Controlling Symptoms of Moderate to Severe Psoriasis: Presented at EADV
10/01/2009 03:56:24 PM
Health Canada Approves Telavancin for Complicated Skin, Skin Structure Infections
09/25/2009 02:24:56 PM
FDA Approves Ustekinumab for Moderate to Severe Psoriasis
09/24/2009 03:04:44 PM
Study Identifies Genetic Cause of Previously Undefined Primary Immune Deficiency Disease
09/23/2009 05:30:31 PM
Merkel Cell Polyomavirus Associated With Merkel Cell Carcinoma
09/23/2009 05:05:42 PM
Ustekinumab Approved by NICE for Moderate to Severe Plaque Psoriasis
09/17/2009 12:00:58 PM
Linezolid, Vancomycin Effective Against Skin Complication in Community or Hospital Infections With Methicillin-Resistant Staphylococcus aureus: Presented at ICAAC
09/14/2009 09:19:42 AM
FDA Approves Telavancin for Complicated Skin and Skin Structure Infections
08/31/2009 03:40:01 PM
Study Reveals New Genetic Mutations Involved in Melanoma
08/26/2009 02:38:01 PM
NICE Guidance Recommends Treatment for Severe Hand Eczema
08/11/2009 05:58:35 PM
Budesonide Fails as Diarrhoea Prophylactic in Melanoma Patients Receiving Ipilimumab
08/10/2009 04:00:51 PM
Study Identifies Risk Factors for Transformation of Choroidal Nevus Into Melanoma
07/20/2009 06:48:29 PM
Clotting in Veins Close to Skin May Be Associated With More Dangerous Deep-Vein Blood Clots
07/02/2009 04:08:35 PM
Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI
06/26/2009 05:54:10 PM
Study Characterises Eczema Patients Most at Risk for Dangerous Viral Infections
06/24/2009 03:42:07 PM
Certain Clinical, Ultrasonographic Characteristics Can Assist in Diagnosing Uveal Melanoma: Presented at COS
06/15/2009 04:35:41 PM
Psoriasis Associated With Cardiovascular Disease, Increased Mortality
06/15/2009 04:32:49 PM
Topical Fluorouracil Reduces Number of Actinic Keratoses, Improves Skin Damage
06/15/2009 03:29:12 PM
Chondroitin Sulphate Effective in Patients With Concomitant Knee Osteoarthritis and Psoriasis: Presented at EULAR
06/15/2009 11:52:06 AM
Golimubab Shows Long-Term Efficacy in Treatment of Psoriatic Arthritis: Presented at EULAR
06/10/2009 02:15:47 PM
Nationwide Recall of Remaining Batches of Efalizumab Initiated in Europe
06/03/2009 01:12:18 PM
Ipilimumab Benefits Patients With Advanced Melanoma Regardless of Immune-Related Adverse Events: Presented at ASCO
06/02/2009 05:07:23 PM
Actinic Keratoses Responsible for More Cancer Types Than Once Believed
06/01/2009 03:19:10 PM
Ipilimumab Demonstrates Favourable Long-Term Survival Rate in Advanced Melanoma: Presented at ASCO
05/31/2009 10:09:13 PM
Novel Vaccine Doubles Response in Patients With Metastatic Melanoma: Presented at ASCO
05/31/2009 12:12:32 PM
Trial of Elesclomol, Paclitaxel in Malignant Melanoma Stopped Due to Higher Death Rate: Presented at ASCO
05/26/2009 05:21:20 PM
Oral Linezolid as Effective as Intravenous Vancomycin in Treating MRSA in Complicated Skin and Soft Tissue Infections: Presented at ECCMID
05/26/2009 04:50:29 PM
Delafloxacin as Effective as Tigecycline in Treating Complicated Skin, Skin Structure Infections: Presented at ECCMID
05/26/2009 02:18:39 PM
Moxifloxacin Effective, Safe for Treatment of Patients With Complicated Skin, Skin Structure Infection: Presented at ECCMID
05/22/2009 11:06:32 AM
Ceftaroline Noninferior to Vancomycin Plus Aztreonam for Complicated Skin and Skin Structure Infections: Presented at ECCMID
05/20/2009 11:21:00 AM
Monotherapy With Quinolones Questionable for Patients With Diabetic Foot Infections: Presented at ECCMID
05/08/2009 05:01:16 PM
FDA Warns of New Serious Adverse Events With Erlotinib
05/08/2009 02:24:40 PM
Gynaecological Skin, Soft-Tissue Infections Should Be Tested for Methicillin-Resistant Staphylococcus aureus: Presented at ACOG
04/28/2009 03:00:28 PM
Low-Dose Finasteride Has Little Impact on PSA Levels of Older Men at Risk for Prostate Cancer: Presented at AUA
04/21/2009 05:10:18 PM
Health Canada Approves Methyl Aminolevulinate Cream for Use With Red Light Technology
04/20/2009 04:00:47 PM
Psoriasis Associated With Hypertension, Diabetes in Women
04/08/2009 05:16:57 PM
Manufacturer of Efalizumab Announces Voluntary Withdrawal From US Market
04/07/2009 04:26:57 PM
Golimumab Significantly Improves Active Psoriatic Arthritis, Nail Psoriasis
04/01/2009 03:38:22 PM
Researchers Identify Gene That Suppresses Tumour Growth in Melanoma
03/17/2009 03:30:19 PM
Sentinel Node Biopsy Encouraged in Melanoma Treatment Guidelines: Presented at NCCN
03/16/2009 04:41:16 PM
Acitretin Therapy May Help Reduce Nail Psoriasis Symptoms
03/13/2009 03:15:27 PM
Adjuvant Epirubicin/Docetaxel Followed by Capecitabine Improves Hair Recovery Compared With Epirubicin/Cyclophosphamide Followed by Docetaxel in Node-Positive Operable Breast Cancer: Presented at SGBCC
03/11/2009 06:41:32 PM
Adalimumab Benefits Broad Span of Psoriasis Patients: Presented at AAD
03/11/2009 02:04:48 PM
Adalimumab Benefits Broad Span of Psoriasis Patients: Presented at AAD
03/11/2009 10:06:38 AM
Patient-Reported Outcomes Favourable With Clindamycin Phosphate Plus Benzoyl Peroxide Gel for Acne Treatment: Presented at AAD
03/10/2009 12:20:53 PM
Clindamycin Phosphate, Benzoyl Peroxide Combination Improves Severe Acne: Presented at AAD
03/10/2009 11:47:28 AM
Etanercept Provides Sustained Efficacy and Safety Benefits in Patients With Psoriasis: Presented at AAD
03/10/2009 07:30:49 AM
Three-Step System Effective for Acne Treatment Without Use of Antibiotic: Presented at AAD
03/10/2009 07:27:31 AM
Desonide Hydrogel for Dermatitis Effective, Results in High Patient Satisfaction: Presented at AAD
03/10/2009 07:23:08 AM
NB-001 0.3% Topical Nanoemulsion Benefits Herpes Patients: Presented at AAD
03/10/2009 07:19:43 AM
Ustekinumab Better Than Etanercept in Plaque Psoriasis: Presented at AAD
03/10/2009 07:13:35 AM
Sentinel Lymph-Node Status Strongly Predicts Survival in Patients With Stage T4 Melanoma: Presented at SSO
03/10/2009 07:10:07 AM
Calcipotriol Plus Betamethasone Dipropionate Formulation Effective in Scalp Psoriasis: Presented at AAD
03/09/2009 04:56:14 PM
Clobetasol Propionate Spray Followed by Calcitriol Ointment Effective for Plaque Psoriasis: Presented at AAD
03/09/2009 03:50:45 PM
Ustekinumab Effective in Broad Span of Psoriasis Patients: Presented at AAD
03/09/2009 12:47:28 PM
Topical Corticosteroids Plus Pimecrolimus Cream 1% as Safe as Corticosteroids Alone in Severe Paediatric Dermatitis: Presented at AAD
03/08/2009 10:53:52 AM
Isolated Limb Infusion May Undertreat Patients With Recurrent Metastatic Melanoma in an Extremity: Presented at SSO
02/19/2009 01:49:21 PM
EMEA Recommends Suspension of Efalizumab, FDA Continues Its Safety Review
02/17/2009 04:05:29 PM
Family History of Melanoma May Indicate Greater Risk of Parkinson's Disease
02/11/2009 06:30:36 PM
Ustekinumab Reduces Symptoms of Psoriatic Arthritis, Diminishes Skin Lesions
02/03/2009 03:37:42 PM
FDA Approves Calcitriol for Mild-to-Moderate Plaque Psoriasis
01/22/2009 10:52:31 AM
Ustekinumab Approved in EU for Moderate to Severe Plaque Psoriasis
01/19/2009 04:14:03 PM
Retinoid Cream Associated With Death in Clinical Trial, but Relationship Does Not Appear Causal
01/19/2009 02:51:14 PM
Prophylactic Skin Care Markedly Reduces Complications in Colorectal Cancer Patients Receiving Treatment With Panitumumab: Presented at ASCO-GI
01/13/2009 04:38:18 PM
Serious Adverse Effects Reported With Use of Botulinum Toxin Type A
01/12/2009 05:08:24 PM
Etanercept Approved in EU for Treatment of Paediatric Psoriasis
01/06/2009 04:23:53 PM
FDA Approves Once-Daily Adapalene/Benzoyl Peroxide Gel for Acne Treatment
12/31/2008 10:39:58 AM
Efalizumab Associated With Serious Infections, Progressive Multifocal Leukoencephalopathy
12/15/2008 05:30:21 PM
Psoriasis Independently Associated With Hyperleptinaemia
12/15/2008 02:38:20 PM
Ustekinumab Approved in Canada for Moderate to Severe Plaque Psoriasis
12/07/2008 06:55:15 PM
Intractable Epilepsy, History of Skin Reaction Predict Rash in Paediatric Patients Receiving Lamotrigine: Presented at AES
11/24/2008 04:51:31 PM
Phenytoin, Fosphenytoin May Increase Risk of Serious Skin Reactions in Asian Patients With HLA-B*1502 Allele
11/13/2008 11:00:06 AM
Swissmedic Approves Ceftobiprole Medocaril for Treatment of Complicated Skin Structure Infections
11/11/2008 04:02:42 PM
Subcutaneous Ecallantide Effective for Treatment of Acute Hereditary Angio-Oedema Episodes: Presented at ACAAI
11/08/2008 04:10:00 PM

[Next Page]